is there still a shortage of semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Drug prescribed for type 2

It's the Plunge

Once you know the big pharmaceutical companies are spending a lot of money looking for glucagon receptor antagonists and testing them, and GIP receptor antagonists and testing them, it requires a lot of gusto, a lot of lunacy and craziness to say, nah, I believe all these big pharmaceutical companies are wrong, my lab is doing the opposite. But now, the sentiment has drastically shifted and many companies are looking to co-agonist drugs to achieve over 20%, or even close to 30% weight loss

A single missing piece of information can lead to a denial, forcing you to start the long and frustrating appeals process

As an FDA-registered 503B facility, Olympia Pharmaceuticals plays a critical role in bridging drug shortages and strengthening your pharmacys supply chain with reliable, high-quality compounded medications

The body as a whole, however, is still functioning relatively well